FI83877C - Foerfarande foer framstaellning av en ny terapeutiskt anvaendbar 7-(3-klorisoxazol-5-yl)-acetamido-3- (1-metyl-1h-1,2,3,4-tetrazol-5-yl)-tiometyl-cef-3-em-4-karboxylsyra - Google Patents

Foerfarande foer framstaellning av en ny terapeutiskt anvaendbar 7-(3-klorisoxazol-5-yl)-acetamido-3- (1-metyl-1h-1,2,3,4-tetrazol-5-yl)-tiometyl-cef-3-em-4-karboxylsyra Download PDF

Info

Publication number
FI83877C
FI83877C FI862965A FI862965A FI83877C FI 83877 C FI83877 C FI 83877C FI 862965 A FI862965 A FI 862965A FI 862965 A FI862965 A FI 862965A FI 83877 C FI83877 C FI 83877C
Authority
FI
Finland
Prior art keywords
methyl
tetrazol
acetamido
formula
carboxylic acid
Prior art date
Application number
FI862965A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI862965A0 (fi
FI862965A (fi
FI83877B (fi
Inventor
Istvan Kovacs
Sandor Jancso
Sandor Elek
Katalin Marossy
Nee Borbely Ildiko Mihok
Ildiko Mihok
Maria Konya
Nee Loos Ilona Kiss
Karoly Lempert
Gabor Doleschall
Jozsef Fetter
Gyula Hornyak
Jozsef Nyitrai
Gyula Simig
Karoly Zauer
Zsuzsanna Gombos
Original Assignee
Biogal Gyogyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar filed Critical Biogal Gyogyszergyar
Publication of FI862965A0 publication Critical patent/FI862965A0/fi
Publication of FI862965A publication Critical patent/FI862965A/fi
Publication of FI83877B publication Critical patent/FI83877B/fi
Application granted granted Critical
Publication of FI83877C publication Critical patent/FI83877C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI862965A 1985-07-16 1986-07-16 Foerfarande foer framstaellning av en ny terapeutiskt anvaendbar 7-(3-klorisoxazol-5-yl)-acetamido-3- (1-metyl-1h-1,2,3,4-tetrazol-5-yl)-tiometyl-cef-3-em-4-karboxylsyra FI83877C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU272585 1985-07-16
HU852725A HU203243B (en) 1985-07-16 1985-07-16 Process for producing cefalosporin derivative

Publications (4)

Publication Number Publication Date
FI862965A0 FI862965A0 (fi) 1986-07-16
FI862965A FI862965A (fi) 1987-01-17
FI83877B FI83877B (fi) 1991-05-31
FI83877C true FI83877C (fi) 1991-09-10

Family

ID=10960853

Family Applications (1)

Application Number Title Priority Date Filing Date
FI862965A FI83877C (fi) 1985-07-16 1986-07-16 Foerfarande foer framstaellning av en ny terapeutiskt anvaendbar 7-(3-klorisoxazol-5-yl)-acetamido-3- (1-metyl-1h-1,2,3,4-tetrazol-5-yl)-tiometyl-cef-3-em-4-karboxylsyra

Country Status (14)

Country Link
JP (1) JPS6222787A (it)
KR (1) KR930007263B1 (it)
CN (1) CN1012614B (it)
AT (1) AT389877B (it)
BE (1) BE905113A (it)
DE (1) DE3623900A1 (it)
FI (1) FI83877C (it)
FR (1) FR2591598B1 (it)
GB (1) GB2177696B (it)
GR (1) GR861855B (it)
HU (1) HU203243B (it)
IL (1) IL79410A0 (it)
IT (1) IT1196494B (it)
NL (1) NL8601842A (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2012729C (en) 1989-04-07 1997-05-20 Takashi Kuroda Dulled stretched molding and process for producing the same
JP2893286B2 (ja) * 1990-05-17 1999-05-17 グンゼ株式会社 熱収縮性発泡複合フィルム及びその製法
JP2515295Y2 (ja) * 1993-06-30 1996-10-30 株式会社川崎製作所 管継手
KR100408343B1 (ko) * 2001-11-01 2003-12-06 주식회사 이앤티 자돈의 항상성(Homeostasis)을 유지시킬 수 있는 사료 및그 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7402778A (it) * 1973-03-02 1974-09-04
JPS539787A (en) * 1976-07-16 1978-01-28 Yamanouchi Pharmaceut Co Ltd Novel cephalosporin derivatives and their preparation

Also Published As

Publication number Publication date
FI862965A0 (fi) 1986-07-16
BE905113A (fr) 1986-11-03
ATA192686A (de) 1989-07-15
GB2177696B (en) 1989-01-05
JPS6222787A (ja) 1987-01-30
CN86104805A (zh) 1987-02-18
IT1196494B (it) 1988-11-16
FR2591598B1 (fr) 1990-01-26
IL79410A0 (en) 1986-10-31
GR861855B (en) 1986-11-18
HUT48890A (en) 1989-07-28
GB8617181D0 (en) 1986-08-20
CN1012614B (zh) 1991-05-15
KR870001219A (ko) 1987-03-12
KR930007263B1 (ko) 1993-08-04
AT389877B (de) 1990-02-12
FR2591598A1 (fr) 1987-06-19
DE3623900A1 (de) 1987-01-29
HU203243B (en) 1991-06-28
FI862965A (fi) 1987-01-17
GB2177696A (en) 1987-01-28
IT8621135A0 (it) 1986-07-15
NL8601842A (nl) 1987-02-16
FI83877B (fi) 1991-05-31

Similar Documents

Publication Publication Date Title
KR930007418B1 (ko) 세팔로스포린 화합물, 그의 제조방법
US4201782A (en) Thiadiazolyl cephalosporin analogs
JPS5858354B2 (ja) セフェム誘導体
GB2099418A (en) Cephalosporin derivatives
JPS6145995B2 (it)
KR870001986B1 (ko) 세팔로스포린 유도체의 제조방법
US3929779A (en) Aminopyridinium acetyl cephalosporanes
US3813388A (en) 7-(d-(alpha-amino-alpha-phenyl-,2-thienyl-and 3-thienyl-acetamido))-3-(s-(2-methyl-1,2,3-triazole-4-yl)thiomethyl)-3-cephem-4-carboxylic acids
FI83877C (fi) Foerfarande foer framstaellning av en ny terapeutiskt anvaendbar 7-(3-klorisoxazol-5-yl)-acetamido-3- (1-metyl-1h-1,2,3,4-tetrazol-5-yl)-tiometyl-cef-3-em-4-karboxylsyra
US4061748A (en) 7-(α-(4-Hydroxy-1,5-naphthyridine-3-carbonamido)-α-phenylacetamido) cephalosporin derivatives
US4103008A (en) 7[2(2,3 Dioxopiperazin-1-yl-carbonylamino)substituted 2 phenylacetamido]-3-2'-thiadiazolyl cephalosporanic acid derivatives
US4880798A (en) Cephalosporin derivatives
US4117126A (en) 7-(α-(4-Hydroxy-1,5-naphthyridine-3-carbonamido)-α-phenylacetamido) cephalosporin derivatives
US4183925A (en) 7-Aminophenylacetamido-Δ3 -cephem antibacterial agents and method of use
US4325951A (en) 1-Oxadethiacephalosporin derivatives and antibacterial use thereof
US4080451A (en) Cephalosporin derivatives
Yasuda et al. Synthesis and antibacterial activity of 6-and 7-[2-(5-carboxyimidazole-4-carboxamido) phenylacetamido]-penicillins and cephalosporins
US4160830A (en) Cephalosporins
US4311842A (en) Cephalosporin compounds
US4198504A (en) [3-(Pyridinium)-7-(naphthyiridinyl carbonylamino)acetamido]cephalosporanic acid derivatives
US4179502A (en) 7[2-Hydroxyiminoacetamido]cephalosporins
WO1997024359A1 (en) Novel cephalosporin derivatives and processes for the preparation thereof
US4144240A (en) Substituted mercaptothiadiazole compounds
KR830000678B1 (ko) 세팔로스포린 에스테르 및 에테르의 제조방법
US4144241A (en) 5-Sulfomethyl-1,3,4-thiadiazole-2-thiol

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: BIOGAL GYOGYSZERGYAR RT.